Table 4.
Correlation of different parameters with genital mycotic infection
| Parameters | First episode | P | |
|---|---|---|---|
| Yes (n=53) | No (n=152) | ||
| Age group | |||
| <40 | 5 (9.43) | 8 (5.26) | 0.730 |
| 41-50 | 22 (41.51) | 61 (40.13) | |
| 51-60 | 17 (32.08) | 54 (35.53) | |
| >60 | 9 (16.98) | 29 (19.08) | |
| Sex | |||
| Male | 28 (52.83) | 79 (51.97) | 0.916 |
| Female | 25 (47.17) | 73 (48.03) | |
| Duration of diabetes | |||
| ≤1 year | 35 (66.04) | 108 (71.0) | 0.550 |
| >1 year | 18 (33.96) | 44 (28.9) | |
| Glycaemic control | |||
| ≤7% | 3 (5.66) | 9 (5.9) | 0.521 |
| >7% | 50 (94.34) | 133 (87.5) | |
| SGLT2i | |||
| Empagliflozin | 29 (54.72) | 75 (49.34) | 0.575 |
| Dapagliflozin | 13 (24.53) | 49 (32.24) | |
| Canagliflozin | 11 (20.75) | 28 (18.42) | |
| Duration of treatment | |||
| <6 months | 44 (83) | 109 (71.7) | 0.351 |
| >6 months | 9 (17) | 43 (28.2) | |
| Past history of genital mycotic infections | 11 (20.7) | 14 (9.2) | 0.027 |
We need to add figures where yellow is highlighted